These effects, along with a preceding report demonstrating that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like behavior in mice,two guidance the concept of focusing on ACKR3 as a singular solution to modulate the opioid program, which could open up new therapeutic avenues for opioid-linked disorders. “Overall, the discovery in https://tonyv849pgw6.wikicarrier.com/user